XFOR

MKT CAP:$388M

X4 Pharmaceuticals Inc

Market Cap

$388M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$3.83-$0.06 (-1.54%)

Jun 5, 2026

52W High $4.6652W Low $1.42

Company Details

X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally small-molecule s...

CEO

—

IPO Date

Nov 16, 2017

Website

www.x4pharma.com

Key Metrics TTM

Revenue

$9M

-71.3% YoY

Net Income

-$100M

EPS (Diluted)

Free Cash Flow

-$93M

Revenue / Share

$0.07

Gross Margin

79.4%

Operating Margin

-1084.4%

Net Margin

-1106.3%

FCF Margin

-1030.1%

P/S

43.0x

P/E

Earnings Reports

Q1 2026

May 6, 2026

$3M-90.6%

FY 2025

Mar 17, 2026

$35M+1273.2%

Q4 2025

Mar 17, 2026

$3M+79.1%

Q3 2025

Nov 5, 2025

$2M+215.2%

Q2 2025

Aug 8, 2025

$2M+250.4%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee